[1]

Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, et al. 2018. European society of cardiology: cardiovascular disease statistics 2017. European Heart Journal 39:508−79

doi: 10.1093/eurheartj/ehx628
[2]

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. 2016. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation 133:e38−e360

doi: 10.1161/CIR.0000000000000350
[3]

Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, et al. 2012. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology 60:e44−e164

doi: 10.1016/j.jacc.2012.07.013
[4]

Cheung N, Wong TY. 2008. Diabetic retinopathy and systemic vascular complications. Progress in Retinal and Eye Research 27:161−76

doi: 10.1016/j.preteyeres.2007.12.001
[5]

Sun C, Liew G, Wang JJ, Mitchell P, Saw SM, et al. 2008. Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study. Investigative Ophthalmology & Visual Science 49:1784−90

doi: 10.1167/iovs.07-1450
[6]

Kawasaki R, Wang JJ, Rochtchina E, Taylor B, Wong TY, et al. 2006. Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the funagata study. Ophthalmology 113:1378−84

doi: 10.1016/j.ophtha.2006.02.052
[7]

Wong TY, Islam FMA, Klein R, Klein BEK, Cotch MF, et al. 2006. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Investigative Ophthalmology & Visual Science 47:2341−50

doi: 10.1167/iovs.05-1539
[8]

Ikram MK, de Jong FJ, Vingerling JR, Witteman JCM, Hofman A, et al. 2004. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Investigative Ophthalmology & Visual Science 45:2129−34

doi: 10.1167/iovs.03-1390
[9]

Drobnjak D, Munch IC, Glümer C, Færch K, Kessel L, et al. 2017. Relationship between retinal vessel diameters and retinopathy in the Inter99 Eye Study. Journal of Clinical & Translational Endocrinology 8:22−28

doi: 10.1016/j.jcte.2017.03.002
[10]

Liew G, Sharrett AR, Wang JJ, Klein R, Klein BEK, et al. 2008. Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Archives of Ophthalmology 126:1404−10

doi: 10.1001/archopht.126.10.1404
[11]

Avery CL, Kucharska-Newton A, Monda KL, Richey Sharrett A, Mosley TH, et al. 2012. Impact of long-term measures of glucose and blood pressure on the retinal microvasculature. Atherosclerosis 225:412−17

doi: 10.1016/j.atherosclerosis.2012.10.034
[12]

Wong TY, Shankar A, Klein R, Klein BEK, Hubbard LD. 2004. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 329:79

doi: 10.1136/bmj.38124.682523.55
[13]

Chandra A, Seidelmann SB, Claggett BL, Klein BE, Klein R, et al. 2019. The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study. European Journal of Heart Failure 21:1207−15

doi: 10.1002/ejhf.1564
[14]

Seidelmann SB, Claggett B, Bravo PE, Gupta A, Farhad H, et al. 2016. Retinal vessel calibers in predicting long-term cardiovascular outcomes: the atherosclerosis risk in communities study. Circulation 134:1328−38

doi: 10.1161/CIRCULATIONAHA.116.023425
[15]

Verdecchia P, Reboldi G, Angeli F. 2020. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. European Journal of Internal Medicine 82:1−6

doi: 10.1016/j.ejim.2020.09.001
[16]

Ikram MK, Ong YT, Cheung CY, Wong TY. 2013. Retinal vascular caliber measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica 229:125−36

doi: 10.1159/000342158
[17]

Sauerbrei W, Royston P, Binder H. 2007. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Statistics in Medicine 26:5512−28

doi: 10.1002/sim.3148
[18]

Cheung CY, Xu D, Cheng CY, Sabanayagam C, Tham YC, et al. 2021. A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. Nature Biomedical Engineering 5:498−508

doi: 10.1038/s41551-020-00626-4
[19]

Hanssen H, Streese L, Vilser W. 2022. Retinal vessel diameters and function in cardiovascular risk and disease. Progress in Retinal and Eye Research 91:101095

doi: 10.1016/j.preteyeres.2022.101095
[20]

Antonetti DA, Silva PS, Stitt AW. 2021. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nature Reviews Endocrinology 17:195−206

doi: 10.1038/s41574-020-00451-4
[21]

Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, et al. 2025. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet 405:1264−312

doi: 10.1016/S0140-6736(25)00055-8
[22]

Chen J, Ji X, Zhao R, Wang F. 2023. Association of blood pressure variability and CT-based Leiden score in hypertension patients. Frontiers in Cardiovascular Medicine 10:101111120

doi: 10.3389/fcvm.2023.1111120
[23]

Laghlam D, Jozwiak M, Nguyen LS. 2021. Renin−angiotensin−aldosterone system and immunomodulation: a state-of-the-art review. Cells 10:1767

doi: 10.3390/cells10071767
[24]

Fuchs FD, Whelton PK. 2020. High blood pressure and cardiovascular disease. Hypertension 75:285−92

doi: 10.1161/hypertensionaha.119.14240
[25]

Rusu AC, Horvath KU, Tinica G, Chistol RO, Bulgaru-Iliescu AI, et al. 2024. Retinal structural and vascular changes in patients with coronary artery disease: a systematic review and meta-analysis. Life 14:448

doi: 10.3390/life14040448
[26]

Wong TY, Shankar A, Klein R, Klein BEK, Hubbard LD. 2005. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Archives of Internal Medicine 165:1060−65

doi: 10.1001/archinte.165.9.1060
[27]

Su X, Zhou P, Qi Y. 2022. Down-regulation of LCN2 attenuates retinal vascular dysfunction and caspase-1-mediated pyroptosis in diabetes mellitus. Annals of Translational Medicine 10:695

doi: 10.21037/atm-22-2655
[28]

Lai C, Su T, Cao J, Li Q, Du Z, et al. 2024. Retinal neurovascular impairment in full-course diabetic retinopathy: the Guangdong diabetic retinopathy multiple-omics study. Investigative Ophthalmology & Visual Science 65:20

doi: 10.1167/iovs.65.14.20
[29]

Ikram MK, Janssen JAMJL, Roos AME, Rietveld I, Witteman JCM, et al. 2006. Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506−10

doi: 10.2337/diabetes.55.02.06.db05-0546
[30]

Jeganathan VSE, Sabanayagam C, Tai ES, Lee J, Lamoureux E, et al. 2009. Retinal vascular caliber and diabetes in a multiethnic Asian population. Microcirculation 16:534−43

doi: 10.1080/10739680902975222
[31]

Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. 2001. Systemic diseases associated with various types of retinal vein occlusion. American Journal of Ophthalmology 131:61−77

doi: 10.1016/S0002-9394(00)00709-1
[32]

Stark K, Massberg S. 2021. Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology 18:666−82

doi: 10.1038/s41569-021-00552-1
[33]

Davalos D, Akassoglou K. 2012. Fibrinogen as a key regulator of inflammation in disease. Seminars in Immunopathology 34:43−62

doi: 10.1007/s00281-011-0290-8
[34]

Lin Y, Hu X, Wang W, Yu B, Zhou L, et al. 2022. D-dimer is associated with coronary microvascular dysfunction in patients with non-obstructive coronary artery disease and preserved ejection fraction. Frontiers in Cardiovascular Medicine 9:937952

doi: 10.3389/fcvm.2022.937952
[35]

Steppan J, Sikka G, Jandu S, Barodka V, Halushka MK, et al. 2014. Exercise, vascular stiffness, and tissue transglutaminase. Journal of the American Heart Association 3:e000599

doi: 10.1161/JAHA.113.000599
[36]

Li H, Mitchell P, Rochtchina E, Burlutsky G, Wong TY, et al. 2011. Retinal vessel caliber and myopic retinopathy: the blue mountains eye study. Ophthalmic Epidemiology 18:275−80

doi: 10.3109/09286586.2011.602508
[37]

Lowenstern A, Ng N, Takagi H, Rymer JA, Koweek LM, et al. 2023. Influence of obesity on coronary artery disease and clinical outcomes in the ADVANCE registry. Circulation. Cardiovascular Imaging 16:e014850

doi: 10.1161/CIRCIMAGING.122.014850
[38]

Koenen M, Hill MA, Cohen P, Sowers JR. 2021. Obesity, adipose tissue and vascular dysfunction. Circulation Research 128:951−68

doi: 10.1161/CIRCRESAHA.121.318093
[39]

Chua J, Tan B, Wong D, Garhöfer G, Liew XW, et al. 2024. Optical coherence tomography angiography of the retina and choroid in systemic diseases. Progress in Retinal and Eye Research 10:101292

doi: 10.1016/j.preteyeres.2024.101292
[40]

Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, et al. 2020. The 2020 Canadian cardiovascular society/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Canadian Journal of Cardiology 36:1847−948

doi: 10.1016/j.cjca.2020.09.001
[41]

Staerk C, Byrd A, Mayr A. 2024. Recent methodological trends in epidemiology: No need for data−driven variable selection? American Journal of Epidemiology 193:370−76

doi: 10.1093/aje/kwad193
[42]

Perneger TV. 1998. What’s wrong with Bonferroni adjustments. BMJ 316:1236−38

doi: 10.1136/bmj.316.7139.1236